Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Valerie Greger"'
Publikováno v:
Molecular Genetics & Genomic Medicine
Background Compared with conventional genotyping, which typically tests for a limited number of mutations, next‐generation DNA sequencing (NGS) provides increased accuracy for carrier screening. The objective of this study was to evaluate the cost
Autor:
Valerie Greger, Dana Neitzel, Cynthia Perreault-Micale, Jessica Sullivan, Nicole Faulkner, Stephanie Hallam, Alexander Frieden, Caleb J. Kennedy
Publikováno v:
The Journal of Molecular Diagnostics. 16(6):673-678
Loss of function variants in the PCDH15 gene can cause Usher syndrome type 1F, an autosomal recessive disease associated with profound congenital hearing loss, vestibular dysfunction, and retinitis pigmentosa. The Ashkenazi Jewish population has an i
Autor:
Brenda L. Gallie, Xiaoping Zhu, Bernhard Horsthemke, Wolfgang Höpping, Robert A. Phillips, Eberhard Passarge, Valerie Greger, Audrey D. Goddard
Publikováno v:
Europe PubMed Central
Use of an intragenic BamHI restriction fragment length polymorphism within the 5' end of the retinoblastoma gene (RB1) provided improved genetic counselling for five familial and ten non-familial retinoblastoma patients and their relatives. All other
Publikováno v:
Molecular Genetics & Genomic Medicine
Carrier screening for certain diseases is recommended by major medical and Ashkenazi Jewish (AJ) societies. Most carrier screening panels test only for common, ethnic-specific variants. However, with formerly isolated ethnic groups becoming increasin
Autor:
Stephanie Hallam, Charles Towne, Gregory J. Porreca, Brian Bishop, Patrick Saunders, Caleb J. Kennedy, Valerie Greger, Jodi D. Hoffman, Erin T. Strovel, Jaclyn Schienda, Mark Umbarger, Jocelyn Davie, Miriam G. Blitzer
Publikováno v:
Molecular Genetics & Genomic Medicine
Tay-Sachs disease (TSD) is the prototype for ethnic-based carrier screening, with a carrier rate of ~1/27 in Ashkenazi Jews and French Canadians. HexA enzyme analysis is the current gold standard for TSD carrier screening (detection rate ~98%), but h
Autor:
Benjamin Breton, Marcia M. Nizzari, Gregory J. Porreca, Mark Umbarger, Caleb J. Kennedy, Stephanie Hallam, Niru Chennagiri, Cynthia Micale, John Emhoff, Valerie Greger, George M. Church, Charles F. Towne, David Maganzini, Patrick Saunders
Publikováno v:
Genetics in Medicine
Purpose: Carrier screening for recessive Mendelian disorders traditionally employs focused genotyping to interrogate limited sets of mutations most prevalent in specific ethnic groups. We sought to develop a next-generation DNA sequencing–based wor
Autor:
Chen Hong, Bernhard Horsthemke, Manfred F. Rajewsky, Dieter F. Hülser, Roland Frötschl, Sabine Griegel, Valerie Greger
Retinoblastoma (RB), an intraocular childhood tumor occurring in a hereditary (mostly bilateral) or non-hereditary (unilateral) form, is associated with the inactivation of both alleles of a putative tumor suppressor gene (RB-I) located on chromosome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157937c97e02e70d42cd81783da8897f
Publikováno v:
Human Molecular Genetics. 2:921-924
The majority of cases of the two distinct disorders Prader-Willi syndrome (PWS) and Angelman syndrome (AS) result from cytogenetic deletions of chromosome 15q11-q13. These deletions are exclusively of maternal origin in AS but of paternal origin in P
Autor:
Kai Kloss, Wolfgang Höpping, Eberhard Passarge, Bernhard Horsthemke, Valerie Greger, Elmar P. Messmer, Henning Fritze, Petra Währisch
Publikováno v:
American Journal of Medical Genetics. 39:196-200
DNA samples from 92 unrelated patients with bilateral retinoblastoma were analyzed by Southern blot hybridization with cDNA and genomic clones of the retinoblastoma (RB-1) gene. Qualitative and quantitative evaluation of the Southern blot patterns sh
Autor:
Thomas Hürter, Valerie Greger, Eberhard Passarge, Bernhard Horsthemke, Peter Schirmacher, Antje Bornemann, Jürgen Bohl
Publikováno v:
Cancer. 66:1954-1959
Retinoblastoma tumor formation is initiated by the loss of function of both alleles of the RB-1 gene on chromosome 13. Patients with the hereditary form of retinoblastoma carry a germ line mutation at one of the two homologous gene loci in all cells